You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
Mendeley readers
Title |
Complement inhibitors for age‐related macular degeneration
|
---|---|
Published in |
Cochrane database of systematic reviews, January 2014
|
DOI | 10.1002/14651858.cd009300.pub2 |
Pubmed ID | |
Authors |
Michael A Williams, Gareth J McKay, Usha Chakravarthy |
Abstract |
Given the relatively high prevalence of age-related macular degeneration (AMD) and the increased incidence of AMD as populations age, the results of trials of novel treatments are awaited with much anticipation. The complement cascade describes a series of proteolytic reactions occurring throughout the body that generate proteins with a variety of roles including the initiation and promotion of immune reactions against foreign materials or micro-organisms. The complement cascade is normally tightly regulated, but much evidence implicates complement overactivity in AMD and so it is a logical therapeutic target in the treatment of AMD. |
Mendeley readers
The data shown below were compiled from readership statistics for 148 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 1 | <1% |
Unknown | 147 | 99% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 27 | 18% |
Student > Ph. D. Student | 16 | 11% |
Researcher | 14 | 9% |
Student > Bachelor | 11 | 7% |
Student > Doctoral Student | 9 | 6% |
Other | 19 | 13% |
Unknown | 52 | 35% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 39 | 26% |
Nursing and Health Professions | 14 | 9% |
Agricultural and Biological Sciences | 8 | 5% |
Psychology | 7 | 5% |
Pharmacology, Toxicology and Pharmaceutical Science | 7 | 5% |
Other | 19 | 13% |
Unknown | 54 | 36% |